Analyst calls: Banco Santander upgraded
Lennar and First Solar are downgraded, while AstraZeneca is upgraded.
Information provided by Theflyonthewall.comMonday's noteworthy upgrades include:
- ARM Holdings (ARMH) upgraded to Neutral from Underweight at JPMorgan
- AstraZeneca (AZN) upgraded to Equal Weight from Underweight at Barclays
- BMC Software (BMC) upgraded to Positive from Neutral at Susquehanna
- Banco Santander (STD) upgraded to Conviction Buy from Neutral at Goldman, and to Overweight from Neutral at JPMorgan
- Royal Bank of Canada (RY) upgraded to Buy from Neutral at BofA/Merrill
- Capital One (COF) upgraded to Overweight from Neutral at JPMorgan
- Exxon Mobil (XOM) upgraded to Outperform from Market Perform at Raymond James
- Lions Gate (LGF) upgraded to Above Average from Average at Caris
- Catalyst Health (CHSI) downgraded to Market Perform from Outperform at BMO Capital
- Lennar (LEN) downgraded to Fair Value from Buy at CRT Capital
- Novo Nordisk (NVO) downgraded to Underweight from Equal Weight at Barclays
- Progressive (PGR) downgraded to Neutral from Buy at Citigroup
- First Solar (FSLR) downgraded to Sell with $9 price target at Maxim
MORE ON MSN MONEY
DATA PROVIDERS
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.
STOCK SCOUTER
StockScouter rates stocks from 1 to 10, with 10 being the best, using a system of advanced mathematics to determine a stock's expected risk and return. Ratings are displayed on a bell curve, meaning there will be fewer ratings of 1 and 10 and far more of 4 through 7.
128 | 268 | 471 | 584 | 656 | 593 | 673 | 423 | 262 | 141 |
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 |
LATEST POSTS
The market's cheap money addiction is laid bare. No one knows how it will end.
FIDELITY VIEWPOINTS
- How to sell covered calls - Fidelity Investments
- Savvy year-end tax moves to consider now - Fidelity Investments
- Seven ways to prepare for tax changes
- Five reasons an annual review is crucial - Fidelity Investments
- Take a look at mid caps now - Fidelity Investments
- State of the sector: Health care - Fidelity Investments
VIDEO ON MSN MONEY
ABOUT
Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.
Contributors include professional investors and journalists affiliated with MSN Money.
Follow us on Twitter @topstocksmsn.